Adagio Medical Holdings, Inc. (ADGM) vs Revelation Biosciences, Inc. (REVB)
A side-by-side comparison of Adagio Medical Holdings, Inc. and Revelation Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADGM
Adagio Medical Holdings, Inc.
$0.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
REVB
Revelation Biosciences, Inc.
$0.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ADGM vs REVB
growth of $100 · dividends reinvested · last 2yADGM -98.4% (-87.5%/yr)REVB -99.7% (-94.8%/yr)ADGM compounded faster over this window
Log scale — wide-divergence pair
ADGM REVB
ADGM vs REVB: by the numbers
- •ADGM is the larger company ($3M vs $3M market cap).
Metrics side by side
Valuation
| Metric | ADGM | REVB |
|---|---|---|
| P/B ratio | N/A | 0.29 |
Profitability
| Metric | ADGM | REVB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -106.79% |
| ROIC | -75.31% | -104.28% |
Growth (annualized)
| Metric | ADGM | REVB |
|---|---|---|
| Total return CAGR (5Y) | N/A | -93.52% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.